Novel agents and clinical trials in castration-resistant prostate cancer: latest updates from 2023 ASCO-GU Cancers Symposium

Jiang, YH; Wu, SY; Li, R; Yu, JZ; Zheng, JY; Li, ZY; Li, MY; Xin, KR; Xu, ZQ; Li, SJ; Chen, XN

Xu, ZQ; Li, SJ; Chen, XN (通讯作者),China Med Univ, Dept Urol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023; 12 (1):

Abstract

Numerous novel and effective therapeutic agents and clinical trials addressing castration-resistant prostate cancer (CRPC) were reported during the 20......

Full Text Link